Sign in
Taking people in United StatesNo phase

Talus Replacement Registry

Key facts

Who runs it
Kyle Schweser MD
Where
Columbia, United StatesSee the site
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
1 Jan 2020
Expected to end
1 May 2027
Type of study
Observational
Treatments tested
  • 3D talar augmentation
Record updated
28 April 2026

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Subjects age 18 years or above at time of screening
  • Condition satisfies requirement for total talus replacement
  • Able to consent and participate in the study
  • No previous history of septic arthritis involving the hindfoot/midfoot
  • Previous ability to ambulate

Who cannot take part

  • Active infection, sepsis, osteomyelitis or history of septic arthritis involving the hindfoot/midfoot
  • Condition does not qualify for a total talus replacement
  • Unable to consent or participate in the study secondary to mental status
  • Patients who are pregnant or imprisoned
  • Planned relocation or unable to return for required follow-up visits

Where in United States

  • University of MissouriColumbia, United StatesContact: Ennio R EspositoTaking people

About the trial

What the trial wants to find out

Avascular necrosis of the talus is a difficult problem to manage, especially in the young and healthy. The only option, historically, has been a talectomy and hindfoot fusion. While this is a viable option, it is not without its morbidity. Arthritis of surrounding joints is common, occurring anywhere from 1-10 years after the procedure. This is especially true in younger patients, where loss of motion can be life altering both physically and mentally. The search for alternatives has been limited. Recently, 3D printing has become more ubiquitous and affordable and newer medical alternatives have arisen thanks to this technology. The 3D custom talus is relatively new in the orthopaedic community, but has been used at several centers with good success. It has been shown to re-establish the normal alignment of the foot, preserve motion (with some achieving almost physiologic motion), and allow for almost normal ambulation. However, the data is still limited and further study is necessary. Our facility was recently approved to perform this procedure. Our hypothesis is that custom 3D printed talar body replacements, either used alone or with total ankle replacements, will maintain physiologic motion, have no difference in complications when compared to hindfoot fusions with allograft, lead to good outcome scores and patient satisfaction scores. Patients diagnosed with avascular necrosis of the talus who have already decided to undergo a procedure involving a 3D custom talus as part of their standard care (talar replacement, total ankle/total talus, etc) will be enrolled in the study. Patients will follow standard post-operative protocols and return to clinic at designated time periods (2 weeks, 6 weeks, 3 months, 6 months, 1 year). X-ray evaluation, Range of motion, return to ambulation, walking speed and patient reported outcomes will be evaluated at each visit. Data will then be compared with baseline measurements and use to determine the progression of patients over time after the procedure

The group in the trial

  • 3D talar group

    Patients that will undergo a 3D custom talar augment

    Treatment: 3D talar augmentation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
28 April 2026